A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

• Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models

  2026 Blood Neoplasia article Medicine Lymphoma Diagnosis and Treatment Open access

  0

  citations
• Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma

  2026 HemaSphere article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  0

  citations
• A multi-omics analysis of transformed nodal marginal zone lymphoma

  2025 ESMO rare cancers. article Medicine Lymphoma Diagnosis and Treatment Open access

  1

  citations
• IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center Lymphoma

  2025 The American Journal of Surgical Pathology article Medicine Cutaneous lymphoproliferative disorders research Open access

  1

  citations
• Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment

  2025 Blood Cancer Journal article Medicine Lymphoma Diagnosis and Treatment Open access

  5

  citations
• The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa

  2024 International Journal of Molecular Sciences article Medicine Lymphoma Diagnosis and Treatment Open access

  2

  citations
• Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL

  2024 The Journal of Experimental Medicine article Medicine Lymphoma Diagnosis and Treatment Open access

  19

  citations
• Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

  2024 Blood Advances article Medicine Lymphoma Diagnosis and Treatment Open access

  10

  citations
• Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel

  2023 Hematological Oncology article Medicine Cutaneous lymphoproliferative disorders research Open access

  2

  citations
• Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma

  2023 Neuropathology and Applied Neurobiology article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  4

  citations
• Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

  2023 Blood Advances article Medicine Lymphoma Diagnosis and Treatment Open access

  37

  citations
• Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring

  2022 Cancers article Medicine Cutaneous lymphoproliferative disorders research Open access

  16

  citations
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

  2022 Leukemia article Medicine Lymphoma Diagnosis and Treatment Open access cited by 4 patents

  4,055

  citations
• Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach

  2022 Cancers article Medicine Lymphoma Diagnosis and Treatment Open access

  12

  citations
• Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib

  2021 British Journal of Haematology article Medicine Lymphoma Diagnosis and Treatment Open access cited by 1 patent

  14

  citations

15 results